United States Glaucoma Surgery Devices Market Outlook to 2033 – Glaucoma Drainage Devices and Minimally Invasive Glaucoma Surgery (MIGS) Devices

All the vital news, analysis, and commentary curated by our industry experts.

$4995

Buy Report

Published: December 31, 2025 Report Code: GDME46994CCDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “United States Glaucoma Surgery Devices Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Glaucoma Surgery Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments –

The United States Glaucoma Surgery Devices Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Glaucoma Surgery Devices Market.
• Global corporate-level profiles of key companies operating within the United States Glaucoma Surgery Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Glaucoma Surgery Devices is segmented as follows –

• Glaucoma Drainage Devices

• Minimally Invasive Glaucoma Surgery (MIGS) Devices

Reasons to Buy

The United States Glaucoma Surgery Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Glaukos Corp_x000D_
Allergan Aesthetics_x000D_
New World Medical
Incorporated_x000D_
Alcon Inc

1 Table of Contents

2 Introduction_x000D_

2.1 What Is This Report About?_x000D_

2.2 Glaucoma Surgery Devices Market Segmentation_x000D_

2.3 Definitions of Markets Covered in the Report_x000D_

3 Glaucoma Surgery Devices Market, United States_x000D_

3.1 Glaucoma Surgery Devices Market, United States, Revenue ($m), 2018-2033_x000D_

3.1.1 Glaucoma Drainage Devices Market, United States, Revenue ($m), by Segment, 2018-2033_x000D_

3.2 Glaucoma Surgery Devices Market, United States, Volume (Units), 2018-2033_x000D_

3.2.1 Glaucoma Drainage Devices Market, United States, Volume (Units), by Segment, 2018-2033_x000D_

3.3 Glaucoma Surgery Devices Market, United States, Average Price ($), 2018-2033_x000D_

3.4 Glaucoma Surgery Devices Market, United States, Company Share by Revenue ($m), 2024_x000D_

4 Overview of Key Companies in United States, Glaucoma Surgery Devices Market_x000D_

4.1 Glaukos Corp_x000D_

4.1.1 Company Overview_x000D_

4.2 Allergan Aesthetics_x000D_

4.2.1 Company Overview_x000D_

4.3 New World Medical, Incorporated_x000D_

4.3.1 Company Overview_x000D_

4.4 Alcon Inc_x000D_

4.4.1 Company Overview_x000D_

4.5 Johnson & Johnson Vision Care Inc_x000D_

4.5.1 Company Overview_x000D_

5 Glaucoma Surgery Devices Market Pipeline Products_x000D_

6 Recent Developments_x000D_

6.1 Corporate Communications_x000D_

6.1.1 Oct 14, 2025: Smartlens, Inc. Secures $5.2 Million Bridge Round for FDA Clearance and Commercial Launch of miLens_x000D_

6.1.2 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed_x000D_

6.1.3 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio_x000D_

6.2 Financial Announcements_x000D_

6.2.1 Nov 05, 2025: Ocugen Provides Business Update with Third Quarter 2025 Financial Results_x000D_

6.2.2 Oct 08, 2025: Glaukos To Release Third Quarter 2025 Financial Results After Market Close On October_x000D_

6.2.3 Mar 03, 2025: Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights_x000D_

6.2.4 Feb 11, 2025: STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results_x000D_

6.2.5 Jan 23, 2025: Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February_x000D_

6.2.6 Jan 13, 2025: STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025_x000D_

6.3 Government and Public Interest_x000D_

6.3.1 Nov 03, 2025: Glaukos Announces Participation in Upcoming Investor Conferences_x000D_

6.3.2 Nov 25, 2024: STAAR Surgical to Participate in BTIG Ophthalmology Day_x000D_

6.4 Other Significant Developments_x000D_

6.4.1 Nov 11, 2025: New Publications Highlight OMNI Surgical System's Effectiveness in Reducing IOP_x000D_

6.4.2 Nov 05, 2025: Ocugen Provides Business Update with Third Quarter 2025 Financial Results_x000D_

6.4.3 Oct 07, 2025: Zeiss Expands DORC Portfolio and Strengthens Digital Footprint with Improved Workflow Efficiency and Visualization_x000D_

6.5 Product News_x000D_

6.5.1 Nov 11, 2025: New Publications Highlight OMNI Surgical System's Effectiveness in Reducing IOP_x000D_

6.5.2 Nov 10, 2025: SpyGlass Pharma Reports Positive Results from BIM-IOL System Trials_x000D_

6.5.3 Nov 05, 2025: Ocugen Provides Business Update with Third Quarter 2025 Financial Results_x000D_

6.5.4 Oct 14, 2025: Smartlens, Inc. Secures $5.2 Million Bridge Round for FDA Clearance and Commercial Launch of miLens_x000D_

6.5.5 Oct 07, 2025: Zeiss Expands DORC Portfolio and Strengthens Digital Footprint with Improved Workflow Efficiency and Visualization_x000D_

6.5.6 Oct 06, 2025: Samsara Vision Announces First Pseudophakic Surgery in the PERSPECTIVE Clinical Trial_x000D_

6.5.7 Sep 16, 2025: Alcon Unveils Time and Motion Study Results Demonstrating Enhanced Efficiency for Eye Surgery with UNITY VCS_x000D_

6.5.8 Feb 19, 2025: Early Study Shows Promise for Retinal-Surgery Robot Invented at the University of Utah_x000D_

6.5.9 Nov 20, 2024: Mann Eye Institute First in Texas to Offer Revolutionary Glaucoma Treatment With Voyager DSLT_x000D_

6.6 Strategy And Business Planning_x000D_

6.6.1 Nov 05, 2025: Ocugen Provides Business Update with Third Quarter 2025 Financial Results_x000D_

6.6.2 Oct 31, 2025: Carpenter Eye Associates Joins Metrolina Eye Associates to Expand Eye Care Access_x000D_

6.6.3 Sep 25, 2025: Glaukos Begins Construction of New Facility in Huntsville, Alabama_x000D_

7 Appendix_x000D_

7.1 Research Methodology_x000D_

7.1.1 Coverage_x000D_

7.1.2 Secondary Research_x000D_

7.1.3 Primary Research_x000D_

7.1.4 Market Modeling and Forecasting_x000D_

7.1.5 Company Share Analysis_x000D_

7.1.6 Benchmarking_x000D_

7.2 GlobalData Consulting_x000D_

7.3 Contact Us_x000D_

7.4 Disclaimer

Table

Table 1: Glaucoma Surgery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 2: Glaucoma Drainage Devices Market, United States, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 3: Glaucoma Surgery Devices Market, United States, Volume (Units), 2018-2033_x000D_

Table 4: Glaucoma Drainage Devices Market, United States, Volume (Units), 2018-2033_x000D_

Table 5: Glaucoma Surgery Devices Market, United States, Average Price ($), 2018-2033_x000D_

Table 6: Glaucoma Surgery Devices Market, United States, Company Share by Revenue ($m), 2024_x000D_

Table 7: Glaucoma Surgery Devices Market Pipeline Products_x000D_

Table 8: Total Number of Primary Research Participants, Ophthalmic Devices Market, by Country

Figures

Figure 1: Glaucoma Surgery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 2: Glaucoma Drainage Devices Market, United States, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 3: Glaucoma Surgery Devices Market, United States, Volume (Units), 2018-2033_x000D_

Figure 4: Glaucoma Drainage Devices Market, United States, Volume (Units), 2018-2033_x000D_

Figure 5: Glaucoma Surgery Devices Market, United States, Company Share (%), 2024

United States Glaucoma Surgery Devices Market Outlook to 2033 – Glaucoma Drainage Devices and Minimally Invasive Glaucoma Surgery (MIGS) Devices standard reports

Currency USD

Single User

$4,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Ophthalmic Devices reports

Medical Devices

New

Regulatory Approved Apps Market Size by Segments, Share, Regulatory, Reimbursement,…

Medical Devices

New

Non-Invasive Ventilation Masks and Circuits Market Size by Segments, Share,…

Medical Devices

New

Insulin Pumps and Continuous Glucose Monitors Market Size by Segments,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Glaucoma Surgery Devices Market Outlook to 2033 – Glaucoma Drainage Devices and Minimally Invasive Glaucoma Surgery (MIGS) Devices in real time.

Access a live United States Glaucoma Surgery Devices Market Outlook to 2033 – Glaucoma Drainage Devices and Minimally Invasive Glaucoma Surgery (MIGS) Devices dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

United States Glaucoma Surgery Devices Market Outlook to 2033 – Glaucoma Drainage Devices and Minimally Invasive Glaucoma Surgery (MIGS) Devices

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports